The Goldman Sachs Group, Inc. 13D and 13G filings for Rigel Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-05 5:34 pm Sale | 2023-12-29 | 13G | Rigel Pharmaceuticals, Inc. RIGL | GOLDMAN SACHS GROUP INC GS | 25,568 0.100% | -911,439 (-97.27%) | Filing |
| 2023-02-14 2:40 pm Purchase | 2022-12-30 | 13G | Rigel Pharmaceuticals, Inc. RIGL | GOLDMAN SACHS GROUP INC GS | 937,006 5.400% | 937,006 (New Position) | Filing |